{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-22-000132","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2022-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.091731+00:00","generated_at":"2026-06-27T11:23:18.835524+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quest Diagnostics appoints James E. Davis as CEO-elect; CFO Mark Guinan to retire in 2022","bullets":["James E. Davis appointed CEO-elect effective Feb. 3, 2022; to become CEO and President on Nov. 1, 2022.","Current CEO Steve Rusckowski to remain CEO through Oct. 2022 then serve as Executive Chairman through Mar. 2023.","CFO Mark Guinan announces retirement in 2022; company begins search for successor.","Davis currently EVP of General Diagnostics, overseeing >80% of $10.8B 2021 revenue.","Transition reflects planned succession; no financial impact disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-22-000132","json":"https://secwatch.observer/filing/0000947871-22-000132.json","markdown":"https://secwatch.observer/filing/0000947871-22-000132.md","text":"https://secwatch.observer/filing/0000947871-22-000132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/0000947871-22-000132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/ss773888_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T11:23:18.835524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"088cc82cd2","claim":"Mark J. Guinan departed as Executive Vice President and Chief Financial Officer at QUEST DIAGNOSTICS INC.","evidence_excerpt":"Mark J. Guinan, the Company’s Executive Vice President and Chief Financial Officer, will retire in 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/0000947871-22-000132-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will retire"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"caa5b8dc9d","claim":"Stephen H. Rusckowski changed role as Executive Chairman at QUEST DIAGNOSTICS INC.","evidence_excerpt":"Mr. Rusckowski, 64, currently Chairman, Chief Executive Officer and President, will continue to serve on the Board as Executive Chairman through March 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/0000947871-22-000132-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will serve as Executive Chairman"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"d5ed218a50","claim":"James E. Davis was appointed as Chief Executive Officer – Elect at QUEST DIAGNOSTICS INC.","evidence_excerpt":"appointed James E. Davis, currently Executive Vice President, General Diagnostics, to be its next Chief Executive Officer and President, effective November 1, 2022. In addition, Mr. Davis was appointed Chief Executive Officer – Elect, effective February 3, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000094787122000132/0000947871-22-000132-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer – Elect"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}